Phase 4 Stomach Cancer Trial, Recruiting NCT07139366 Sponsor: Yongquan Shi Condition: Stomach Cancer
Back to Stomach Cancer

Phase 4 Stomach Cancer Trial, Recruiting

NCT07139366
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 75 years, of any gender
  • People whose previous attempts to clear an H. pylori infection with treatment have not worked
  • Women of childbearing age may be eligible if they are not pregnant or breastfeeding, and are willing to use an accepted form of contraception throughout the study and for 30 days after it ends

Who may not be able to join:

  • People who have previously used the antibiotics tetracycline or furazolidone specifically to try to clear an H. pylori infection
  • People who have a medical reason they cannot take the study medications
  • People with serious problems affecting major organs, or severe or unstable heart, lung, or hormonal conditions
  • People who regularly use anti-ulcer medications, including proton-pump inhibitors (acid-reducing drugs) taken within 2 weeks before a specific breath test, or who have used antibiotics or bismuth-containing medicines more than 3 times in the month before screening
  • Women who are pregnant or breastfeeding
  • People who have had surgery on the upper part of the digestive system
  • People who have difficulty swallowing
  • People with signs of gastrointestinal bleeding or iron-deficiency anaemia
  • People with a history of cancer
  • People with a history of drug or alcohol misuse in the past year
  • People who regularly use corticosteroids, anti-inflammatory drugs, blood thinners, or medications that affect platelet function (except low-dose aspirin under 100 mg per day)
  • People with a diagnosed mental health disorder
  • People who have taken part in another clinical trial within the past 3 months
  • People who decline to sign the informed consent form

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: 86-29-84771515

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Yongquan Shi
Registry
ClinicalTrials.gov
Start date
28 October 2025
Est. completion
1 September 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Helicobacter pylori eradication

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov